DE60210976D1 - Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung - Google Patents

Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Info

Publication number
DE60210976D1
DE60210976D1 DE60210976T DE60210976T DE60210976D1 DE 60210976 D1 DE60210976 D1 DE 60210976D1 DE 60210976 T DE60210976 T DE 60210976T DE 60210976 T DE60210976 T DE 60210976T DE 60210976 D1 DE60210976 D1 DE 60210976D1
Authority
DE
Germany
Prior art keywords
prevention
treatment
phenyl
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60210976T
Other languages
English (en)
Other versions
DE60210976T2 (de
Inventor
Carlos Plata-Salaman
Boyu Zhao
Roy Twyman
Moon Choi
Robert Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60210976D1 publication Critical patent/DE60210976D1/de
Publication of DE60210976T2 publication Critical patent/DE60210976T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60210976T 2001-02-27 2002-02-21 Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung Expired - Lifetime DE60210976T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US271681P 2001-02-27
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
DE60210976D1 true DE60210976D1 (de) 2006-06-01
DE60210976T2 DE60210976T2 (de) 2007-05-24

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210976T Expired - Lifetime DE60210976T2 (de) 2001-02-27 2002-02-21 Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Country Status (27)

Country Link
US (1) US6562867B2 (de)
EP (1) EP1408953B1 (de)
JP (1) JP4276837B2 (de)
KR (1) KR100946944B1 (de)
CN (1) CN1250215C (de)
AT (1) ATE324108T1 (de)
BR (1) BR0207644A (de)
CA (1) CA2439475C (de)
CY (1) CY1105330T1 (de)
CZ (1) CZ20032300A3 (de)
DE (1) DE60210976T2 (de)
DK (1) DK1408953T3 (de)
ES (1) ES2262801T3 (de)
HK (1) HK1063436A1 (de)
HU (1) HUP0303243A3 (de)
IL (1) IL157590A0 (de)
MX (1) MXPA03007717A (de)
MY (1) MY129304A (de)
NO (1) NO20033802L (de)
NZ (1) NZ527988A (de)
PL (1) PL364638A1 (de)
PT (1) PT1408953E (de)
RS (1) RS50677B (de)
RU (1) RU2300372C2 (de)
TW (1) TWI250872B (de)
WO (1) WO2002067921A1 (de)
ZA (1) ZA200307465B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ATE324107T1 (de) * 2001-02-27 2006-05-15 Ortho Mcneil Pharm Inc Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
PL364680A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
HUP0401367A2 (hu) 2001-07-16 2004-12-28 Ortho-Mcneil Pharmaceutical, Inc. Karbamátvegyületek alkalmazása neuropátiás fájdalom, valamint cluster és migrénes fejfájással társuló fájdalom megelőzésére vagy kezelésére
US20060194873A1 (en) * 2004-09-16 2006-08-31 Choi Yong M Methods of treating epileptogenesis and epilepsy
TWI419681B (zh) * 2005-06-08 2013-12-21 Sk Biopharmaceuticals Co Ltd 胺基甲酸酯用於製造供治療白天過度嗜睡（eds）的藥物之用途
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EA200970436A1 (ru) * 2006-10-30 2009-12-30 Янссен Фармацевтика, Н.В. Соединения карбамата для лечения депрессии
US20080103199A1 (en) * 2006-10-31 2008-05-01 Haas Magali Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN105189451A (zh) * 2013-03-12 2015-12-23 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
WO2018111008A1 (ko) 2016-12-14 2018-06-21 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CA2439475C (en) 2010-05-18
ZA200307465B (en) 2005-03-17
CA2439475A1 (en) 2002-09-06
YU67803A (sh) 2006-08-17
US6562867B2 (en) 2003-05-13
TWI250872B (en) 2006-03-11
CN1250215C (zh) 2006-04-12
CN1505506A (zh) 2004-06-16
KR20030087010A (ko) 2003-11-12
KR100946944B1 (ko) 2010-03-15
RU2300372C2 (ru) 2007-06-10
NO20033802L (no) 2003-10-22
WO2002067921A1 (en) 2002-09-06
ES2262801T3 (es) 2006-12-01
HUP0303243A2 (hu) 2004-01-28
JP2004533415A (ja) 2004-11-04
HUP0303243A3 (en) 2012-07-30
HK1063436A1 (en) 2004-12-31
DE60210976T2 (de) 2007-05-24
EP1408953B1 (de) 2006-04-26
IL157590A0 (en) 2004-03-28
CY1105330T1 (el) 2010-03-03
EP1408953A1 (de) 2004-04-21
RU2003128997A (ru) 2005-03-20
PT1408953E (pt) 2006-07-31
BR0207644A (pt) 2004-03-09
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
PL364638A1 (en) 2004-12-13
US20020198257A1 (en) 2002-12-26
RS50677B (sr) 2010-06-30
CZ20032300A3 (cs) 2005-01-12
JP4276837B2 (ja) 2009-06-10
MY129304A (en) 2007-03-30
DK1408953T3 (da) 2006-08-21
NO20033802D0 (no) 2003-08-26
ATE324108T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
DE602005020667D1 (de) Verwendung von 2-phenyl-1,2-ethanediol-(di)carbamaten zur behandlung von epileptogenese
ATE538784T1 (de) Verfahren zur behandlung von substanzbedingten erkrankungen
DE60210976D1 (de) Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
ATE378046T1 (de) Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
RS67603A (en) Carbamate compounds for use in the treatment of pain
DE60210960D1 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
PT1305082E (pt) Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca
DE60232796D1 (de) Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders

Legal Events

Date Code Title Description
8364 No opposition during term of opposition